Multicenter phase II study of iodine-131 tositumomab for chemotherapy-relapsed/refractory low-grade and transformed low-grade B-cell non-Hodgkin's lymphomas.

Source:http://linkedlifedata.com/resource/pubmed/id/10715303

Download in:

View as

Triples

General Info

PMID
10715303